Angeliki Georgopoulos

Title: The Innovative Contributions of Angeliki Georgopoulos

Introduction

Angeliki Georgopoulos is a notable inventor based in Minneapolis, MN (US). She has made significant strides in the field of medical technology, particularly in the administration of insulin. Her innovative approach aims to improve the delivery of this essential medication to patients.

Latest Patents

Georgopoulos holds a patent for a method of administering insulin. This method involves delivering insulin through the lungs using an aerosolized mist of small particles. The design of the associated medicament delivery chamber is crucial, as it regulates the flow rate to less than about 30 liters per minute. This innovative technique has been shown to achieve a medication penetration into the lungs of approximately 90%.

Career Highlights

Angeliki Georgopoulos is affiliated with Johns Hopkins University, where she continues to contribute to advancements in medical technology. Her work focuses on enhancing the efficacy of insulin delivery systems, which is vital for patients with diabetes.

Collaborations

Georgopoulos has collaborated with esteemed colleagues, including Beth L. Laube and G. Kenneth Adams III. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Angeliki Georgopoulos exemplifies the spirit of innovation in the medical field. Her contributions, particularly in insulin delivery methods, have the potential to significantly improve patient outcomes.